Antibodies in patients with neuropsychiatric systemic lupus erythematosus

Neurology

Volumn 74, Issue 17, 2010, Pages 1372-1379

  Kimura, A ^a   Kanoh, Y ^a   Sakurai, T ^a   Koumura, A ^a   Yamada, M ^a   Hayashi, Y ^a   Tanaka, Y ^a   Hozumi, I ^a   Takemura, M ^a   Seishima, M ^a   Inuzuka, T ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; METHYLPREDNISOLONE; PREDNISOLONE; PSYCHOTROPIC AGENT;

ACUTE CONFUSION; ADOLESCENT; ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; CHOREA; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MENINGOENCEPHALITIS; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; SEIZURE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 77951705222     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181dad590     Document Type: Article

References (23)

1. Denburg JA, Carbotte RM, Denburg SD. Neuronal antibodies and cognitive function in systemic lupus erythema-tosus. Neurology 1987;37:464-467.
2. van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int 1991;11:1-11.
3. Bluestein HG, Zvaifler NJ. Brain-reactive lymphocyto-toxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976;57:509-516.
4. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41:1819-1827. (Pubitemid 28465536)
5. Zandman-Goddard G, Chapman J, Shoenfeld Y. Auto-antibodies involved in neuropsychiatric SLE and an-tiphospholipid syndrome. Semin Arthritis Rheum 2007;36:297-315. (Pubitemid 46517634)
6. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
7. Stojanovich L, Zandman-Goddard G, Pavlovich S, Si-kanich N. Psychiatric manifestations in systemic lupus er-ythematosus. Autoimmun Rev 2007;6:421-426. (Pubitemid 46824096)
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
9. Nishimura N, Nakamura H, Takai Y, Sano K. Molecular cloning and characterization of two rab GDI species from rat brain: brain-specific and ubiquitous types. J Biol Chem 1994;269:14191-14198.
10. Nishimura N, Goji J, Nakamura H, Orita S, Takai Y, Sano K. Cloning of a brain-type isoform of human Rab GDI and its expression in human neuroblastoma cell lines and tumor specimens. Cancer Res 1995;55:5445-5450.
11. Fischer von Mollard G, Südhof TC, Jahn R. A small GTP-binding protein dissociates from synaptic vesicles during exocytosis. Nature 1991;349:79-81. (Pubitemid 21912020)
12. Schalk I, Zeng K, Wu SK, et al. Structure and mutational analysis of Rab GDP-dissociation inhibitor. Nature 1996; 381:42-48. (Pubitemid 26129998)
13. D'Adamo P, Menegon A, Lo Nigro C, et al. Mutations in GDI1 are responsible for X-linked non-specific mental retardation [erratum 1998;19:303]. Nat Genet 1998;19: 134-139. (Pubitemid 28248793)
14. D'Adamo P, Welzl H, Papadimitriou S, et al. Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in mice. Hum Mol Genet 2002;11:2567-2580. (Pubitemid 35174687)
15. Sakane A, Manabe S, Ishizaki H, et al. Rab3 GTPase-activating protein regulates synaptic transmission and plasticity through the inactivation of Rab3. Proc Natl Acad Sci USA 2006;103:10029-10034. (Pubitemid 43993617)
16. Deng SX, Hanson E, Sanz I. In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibod-ies. Int Immunol 2000;12:415-1123 (Pubitemid 30199346)
17. Seddiki N, Nato F, Lafaye P, Amoura Z, Piette JC, Mazié JC. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J Immunol 2001;166:6423-6429. (Pubitemid 32440777)
18. Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology 2008;47:1498-1502.
19. Williams RC, Jr., Sugiura K, Tan EM. Antibodies to microtubule-associated protein 2 in patients with neuro-psychiatric systemic lupus erythematosus. Arthritis Rheum 2004;50:1239-1247. (Pubitemid 38480835)
20. Tin SK, Xu Q, Thumboo J, Lee LY, Tse C, Fong KY. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures. J Neuroimmunol 2005;169:153-160. (Pubitemid 41527101)
21. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-1193. (Pubitemid 33063773)
22. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jon-sson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005;12:392-398. (Pubitemid 40524182)
23. Stephenson FA. Subunit characterization of NMDA receptors. Curr Drug Targets 2001;2:233-239.